Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions

被引:4
|
作者
Spinillo, A
Debiaggi, M
Zara, F
Maserati, R
Polatti, F
De Santolo, A
机构
[1] Univ Pavia, Dept Obstet & Gynaecol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Infect Dis & Microbiol, I-27100 Pavia, Italy
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2001年 / 108卷 / 06期
关键词
D O I
10.1111/j.1471-0528.2001.00141.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To assess HIV-related nucleic acids in cervico-vaginal secretions and the factors associated with them. Design Observational study. Setting Department of Obstetrics and Gynaecology, University of Pavia, Italy. Population HIV-positive patients attending a cytology service. Methods Paired blood and cervico-vaginal lavage samples were obtained from 122 known HIV-seropositive patients during periodic visits for cytologic screening for lower genital tract neoplasia. Vaginal specimens for the diagnosis of bacterial vaginosis, trichomonas vaginalis and candida infection were also obtained. HIV-1-RNA in plasma, proviral HIV-1-DNA, cell associated and cell-free HIV-1-RNA in cervico-vaginal secretions were quantitatively evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). Main outcome measure Prevalences of HIV related nucleic acids in cervico-vaginal secretions and their univariate and multivariate associations with clinical variables. Results Proviral HIV-1 DNA, cell-associated and cell-free HIV-1 RNA were detected in 50% (61/122), 37.7% (46/122) and 32.8% (40/122) of the patients, respectively. In logistic regression analysis, the presence of HIV-1 RNA in blood was the factor which correlated best with the detection of HIV-1 DNA (OR = 5.48, 95% CI = 2.28-13.20), cell-associated (OR = 4.85; 95% CI = 1.89-12.45) and cell-free HIV-1 RNA (OR = 4.63, 95% CI = 1.74-12.33) in cervico-vaginal samples. However, between 20% and to 35% of patients who tested negative for blood HIV-1 RNA were positive for either HIV-1 DNA or HIV-1 RNA detection in cervico-vaginal lavages. Bacterial vaginosis was associated with an increased prevalence of cell-associated (OR = 3.58, 95% CI = 1.22-10.54) and cell-free HIV-1 RNA(OR = 2.94, 95% CI = 1.0-8.7) detection in cervico-vaginal secretions. Additional factors associated with increased prevalence of HIV-1 RNA detection were advanced stage of HIV disease and vulvovaginal candidiasis. Conclusions Although the presence of HIV-1 RNA in blood is the factor which correlates best with the detection of HIV-related nucleic acids in cervico-vaginal secretions, the shedding of HIV in the genital tract can occur in 20-30% of non-viremic subjects. Bacterial vaginosis and candida infection could have a facilitating role in local HIV viral replication and shedding.
引用
收藏
页码:634 / 641
页数:8
相关论文
共 50 条
  • [41] Human immunodeficiency virus type 1-related transient neurological deficits
    Brew, BJ
    Miller, J
    AMERICAN JOURNAL OF MEDICINE, 1996, 101 (03): : 257 - 261
  • [42] EXAMINATION OF BRAINS OF AIDS CASES FOR HUMAN IMMUNODEFICIENCY VIRUS AND HUMAN CYTOMEGALO-VIRUS NUCLEIC-ACIDS
    WALKER, DG
    ITAGAKI, S
    BERRY, K
    MCGEER, PL
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (05): : 583 - 590
  • [43] Factors associated with oropharyngeal human immunodeficiency virus shedding
    Zuckerman, RA
    Whittington, WLH
    Celum, CL
    Collis, T
    Lucchetti, A
    Sanchez, JL
    Hughes, JP
    Sanchez, JL
    Coombs, RW
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01): : 142 - 145
  • [44] Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion
    Busch, MP
    Operskalski, EA
    Mosley, JW
    Lee, TH
    Henrard, D
    Herman, S
    Sachs, DH
    Harris, M
    Huang, W
    Stram, DO
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (01): : 26 - 33
  • [45] FACTORS IMPACTING HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1 CORECEPTOR TROPISM
    Altamura, M.
    Scudeller, L.
    Volpe, A.
    Saracino, A.
    Ladisa, N.
    Santoro, C.
    Monno, L.
    Angarano, G.
    INFECTION, 2011, 39 : S50 - S50
  • [46] Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase
    McDougall, B
    King, PJ
    Wu, BW
    Hostomsky, Z
    Reinecke, MG
    Robinson, WE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 140 - 146
  • [47] Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein
    Stoylov, SP
    Vuilleumier, C
    Stoylova, E
    DeRocquigny, H
    Roques, BP
    Gerard, D
    Mely, Y
    BIOPOLYMERS, 1997, 41 (03) : 301 - 312
  • [48] Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection
    Alexander, L
    Weiskopf, E
    Greenough, TC
    Gaddis, NC
    Auerbach, MR
    Malim, MH
    O'Brien, SJ
    Walker, BD
    Sullivan, JL
    Desrosiers, RC
    JOURNAL OF VIROLOGY, 2000, 74 (09) : 4361 - 4376
  • [49] Intrabodies to human immunodeficiency virus type 1
    Paillard, F
    HUMAN GENE THERAPY, 1999, 10 (09) : 1425 - 1427
  • [50] Assembling the human immunodeficiency virus type 1
    Cimarelli, A
    Darlix, JL
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (07) : 1166 - 1184